Europe: Goldman Sachs mandated on two European healthcare sales

US bank Goldman Sachs has reportedly been mandated to manage the sale of two significant healthcare companies in Europe: Fresenius’ blood transfusion business and healthcare technology management services firm Althea. Frankfurter Allgemeine Zeitung reports that German healthcare group Fresenius has hired Goldman Sachs to manage the sale of the group’s blood transfusion business, part of…

You must be a HMI Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »